Phase 4 N=129 Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis
Vasomotor Rhinitis
Primary: Mean Change in 2-week rTNSS From Baseline — 5.9; 6.5 Units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=22 Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED)
Hypercholesterolemia · Coronary Arteriosclerosis
Primary: Low Density Lipoprotein-cholesterol (LDL-C) at Baseline and After 6 Weeks of Treatment With Ezetimibe 10 mg Added to Atorvastatin 10 mg Versus Placebo Added to…
Phase 4 N=1,225 Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)
Methicillin Resistant Staphylococcus Aureus (MRSA)
Primary: Clinical Outcome in Participants With Baseline Methicillin Resistant Staphylococcus Aureus (MRSA) at End of Study (EOS) for PP Population — 95; 81; 70; 93 Participants…
Phase 4 N=222 Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU)
Invasive Candidiasis
Primary: Proven and Probable Invasive Candidiasis Based on Modified Mycoses Study Group/European Organization for Research and Treatment of Cancer (MSG/EORTC) Criteria. — 9.8…
Phase 4 N=240 Sequential and Hybrid Therapies for H Pylori Infection
Helicobacter Pylori Infection
Primary: Number of Participants in Which H. Pylori Was Eradicated — 94; 99 participants
Phase 4 N=188 A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042)(COMPLETED)
Opiate Dependence · Drug Dependence · Substance Dependence
Primary: Responders at Day 3 — 85; 85; 8; 9 Participants
Phase 4 N=321 A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder
Panic Disorder
Primary: Mean Change From Baseline in Panic and Agoraphobia Scale (PAS) Total Score at the End of Treatment Phase — -17.4; -17.0 Scores on scale
Phase 4 N=39 Proton Magnetic Spectroscopy in Children and Adolescents With ADHD Before and After Treatment With OROS Methylphenidate
ADHD
Primary: Proton Magnetic Resonance Spectroscopy (H MRS) Scan Results - Glutamate(Glu)/Myo-inositol-containing Compounds (Ino) — 1.50; 1.56 MRS Ratio
Phase 4 N=176 Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol.
Type 2 Diabetes Mellitus
Primary: Hospital Length of Stay — 2.7; 3.1 days — p=0.58
Phase 4 N=125 Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension
Hypertension
Primary: Change From Baseline to Week 38 in the Carotid-femoral Pulse Wave Velocity (PWV) — -1.9; -1.7 m/s
Phase 4 N=451 8 Weeks Study to Evaluate the Efficacy and Safety of Valsartan in Combination With Aliskiren Compared to Valsartan Alone in Patients With Stage 2 Hypertension
Stage 2 Hypertension
Primary: Change From Baseline in Mean Sitting Systolic Blood Pressure (MSSBP) at Week 8 — 164.8; 166.2; 142.3; 145.6 mm Hg — p=0.295
Phase 4 N=51 Rapid Sternal Closure System (TALON)
Sternal Wound Infection · Mediastinitis
Primary: Percentage Change of Preoperative Incentive Spirometry (IS) Volume Achieved — 58; 67 percentage change — p=0.41
Phase 4 N=394 ASCERTAIN: Assessment of Everolimus in Addition to Calcineurin Inhibitor Reduction in the Maintenance of Renal Transplant Recipients
Renal Transplantation
Primary: Renal Function Assessed by Measured GFR (mGFR) — 46.02; 48.00; 46.60 mL/min/1.73m^2 — p=0.6332
Phase 4 N=250 The Glucosamine-study: The Effect of Glucosamine in Treatment of Chronic Low Back Pain
Low Back Pain
Primary: Roland Morris Disability Questionnaire — 9; 9 units on a scale (0-24) — p=0.05
Phase 4 N=31 The Impact of Treating Staphylococcus Aureus Infection and Colonization on the Clinical Severity of Atopic Dermatitis
Atopic Dermatitis
Primary: Change in Eczema Area and Severity Index (EASI)Scores According to Location — -1.06; -0.57; -4.94; -0.88 Change in EASI Score